Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Intelon Optics
AddedFeb 13, 2024
UpdatedJun 18, 2026
Intelon Optics

Intelon Optics

Series A

Intelon Optics: Innovating medical devices with our Brillouin Optical Scanner System.

HQ
Lexington, MA, US
Founded
2013
Overview
Compare
Fundraising
Employees

Intelon Optics is a medical device company dedicated to innovating healthcare through its Brillouin Optical Scanner System. This advanced technology focuses on providing precise, non-invasive measurements of tissue biomechanics, enhancing diagnostic capabilities in ophthalmology and other medical fields.

Intelon Optics has made significant strides in the medical device industry, impacting patient care with its cutting-edge technology. The company’s achievements include successful clinical trials and partnerships with leading healthcare institutions, positioning it as a key player in medical diagnostics.

Intelon Optics - Similar Companies

International Biomedical Devices logo

International Biomedical Devices

aperturectc.com

Iscience Surgical logo

Iscience Surgical

Neuroptics logo

Neuroptics

neuroptics.com

MicroOptx logo

MicroOptx

Opticent Health logo

Opticent Health

opticenthealth.com

Optiscan Biomedical logo

Optiscan Biomedical

optiscancorp.com

Optikos logo

Optikos

optikos.com

InLight Solutions logo

InLight Solutions

Precision Optics logo

Precision Optics

poci.com

CardioOptics logo

CardioOptics

Optovue logo

Optovue

Advanced Optronics logo

Advanced Optronics

IntuBlade logo

IntuBlade

intublade.com

Intelomed logo

Intelomed

intelomed.com

Rebion logo

Rebion

Intelon Optics - Quick Facts

Who are Intelon Optics' competitors?

Companies similar to Intelon Optics include International Biomedical Devices, Iscience Surgical, Neuroptics and MicroOptx.

When was Intelon Optics founded?

Intelon Optics was founded in 2013.

Where is Intelon Optics' headquarters located?

Intelon Optics' headquarters is located in Lexington, MA, US.

When was Intelon Optics' last funding round?

Intelon Optics' most recent funding round was for $6.7B (USD) in October 2018.

How much has Intelon Optics raised to-date?

As of Oct 25, 2018, Intelon Optics has raised a total of $7.7B (USD).

How many employees does Intelon Optics have?

Intelon Optics has 15 employees as of Feb 5, 2024.

Intelon Optics - Classification

Ownership
  • Private
Technology
  • Biotech
  • HealthTech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Hardware
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 1 more industry code
NAICS
  • 623000Nursing and Residential Care Facilities